HPV vaccine development after more than ten years approval

Majalah Obstetri & Ginekologi

View Publication Info
Field Value
Title HPV vaccine development after more than ten years approval
Creator Askandar, Brahmana
Subject HPV; effectiveness; immunogenicity; HPV nonavalent
Description At present, ten years have passed since the human papillomavirus (HPV) vaccine was first approved for use in humans. Research related to HPV vaccine, both in terms of effectiveness and immugenicity in its development, has been widely carried out, such as in terms of the indications of the HPV vaccine use that is not only for preventing cervical cancer, the guidelines for administering 2-dose HPV vaccines for those under 15 years of age, and the discovery of the latest HPV vaccine types: nonavalent HPV vaccine. This review literature discusses all aspects of the development of HPV vaccine since it was first approved for use in humans in 2006.
Publisher Department of Obstetrics and Gynecology, Faculty of Medicine, Airlangga University
Date 2020-06-26
Type info:eu-repo/semantics/article
Peer-reviewed Article
Format application/pdf
Identifier http://e-journal.unair.ac.id/MOG/article/view/20257
Source Majalah Obstetri dan Ginekologi; Vol 28, No 1 (2020): April; 39-43
Language eng
Relation http://e-journal.unair.ac.id/MOG/article/view/20257/11141
Rights Copyright (c) 2020 Majalah Obstetri dan Ginekologi

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library